S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Macron booed by French farmers who blame him for not doing enough to support agriculture
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Macron booed by French farmers who blame him for not doing enough to support agriculture
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Macron booed by French farmers who blame him for not doing enough to support agriculture
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Macron booed by French farmers who blame him for not doing enough to support agriculture
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
NASDAQ:CLOV

Clover Health Investments (CLOV) Stock Price, News & Analysis

$0.90
-0.02 (-2.17%)
(As of 02/23/2024 ET)
Today's Range
$0.89
$0.93
50-Day Range
$0.90
$1.05
52-Week Range
$0.71
$1.63
Volume
7.32 million shs
Average Volume
6.81 million shs
Market Capitalization
$440.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.92

Clover Health Investments MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
112.3% Upside
$1.92 Price Target
Short Interest
Healthy
5.68% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.38mentions of Clover Health Investments in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.48) to ($0.10) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.29 out of 5 stars

Medical Sector

541st out of 939 stocks

Hospital & Medical Service Plans Industry

10th out of 11 stocks


CLOV stock logo

About Clover Health Investments Stock (NASDAQ:CLOV)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.

CLOV Stock Price History

CLOV Stock News Headlines

CLOV Mar 2024 1.000 put
Elon Musk's "Project Dojo" is a Game-Changer
Morgan Stanley predicts that Musk's latest act will boost Tesla's shares by 80% in the next 12 months. But if you want to profit from this development, you'll buy the firm that could see its sales explode by 829% as "Project Dojo" sweeps the nation.
Clover Health Investments Corp. Cl A
CLOV Feb 2024 1.500 call
CLOV Feb 2024 0.500 put
Elon Musk's "Project Dojo" is a Game-Changer
Morgan Stanley predicts that Musk's latest act will boost Tesla's shares by 80% in the next 12 months. But if you want to profit from this development, you'll buy the firm that could see its sales explode by 829% as "Project Dojo" sweeps the nation.
Clover Health CFO Scott Leffler To Leave; Backs FY23 Outlook
CLOV Clover Health Investments, Corp.
See More Headlines
Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/25/2024
Next Earnings (Estimated)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
N/A
Current Symbol
NASDAQ:CLOV
Fax
N/A
Employees
656
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.92
High Stock Price Target
$3.00
Low Stock Price Target
$1.25
Potential Upside/Downside
+112.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-338,840,000.00
Pretax Margin
-9.35%

Debt

Sales & Book Value

Annual Sales
$3.48 billion
Book Value
$0.73 per share

Miscellaneous

Free Float
381,240,000
Market Cap
$440.24 million
Optionable
Optionable
Beta
1.91
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Vivek  GaripalliMr. Vivek Garipalli (Age 45)
    Co-Founder & Executive Chairman
  • Mr. Andrew Toy (Age 45)
    Co-Founder, CEO & Director
    Comp: $1.01M
  • Mr. Brady Priest J.D. (Age 47)
    Chief Executive Officer of Home Care
    Comp: $587.36k
  • Mr. Terrence Ronan (Age 64)
    Interim CFO, Principal Financial Officer & Principal Accounting Officer
  • Mr. Conrad Wai (Age 43)
    Chief Technology Officer
  • Mr. Derrick L. Nueman
    Head of Investor Relations & Corporate strategy
  • Ms. Wendy Richey
    Chief Compliance Officer
  • Ms. Karen Soares
    General Counsel, Senior VP & Corporate Secretary
  • Ms. Rachel Fish
    Chief People Officer
  • Ms. Jamie L. Reynoso (Age 54)
    Chief Executive Officer of Medicare Advantage
    Comp: $461.74k














CLOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Clover Health Investments stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
View CLOV analyst ratings
or view top-rated stocks.

What is Clover Health Investments' stock price target for 2024?

3 brokerages have issued 12 month target prices for Clover Health Investments' shares. Their CLOV share price targets range from $1.25 to $3.00. On average, they predict the company's stock price to reach $1.92 in the next year. This suggests a possible upside of 112.3% from the stock's current price.
View analysts price targets for CLOV
or view top-rated stocks among Wall Street analysts.

How have CLOV shares performed in 2024?

Clover Health Investments' stock was trading at $0.9521 at the beginning of 2024. Since then, CLOV stock has decreased by 5.2% and is now trading at $0.9028.
View the best growth stocks for 2024 here
.

Are investors shorting Clover Health Investments?

Clover Health Investments saw a drop in short interest during the month of January. As of January 31st, there was short interest totaling 27,680,000 shares, a drop of 7.9% from the January 15th total of 30,040,000 shares. Based on an average trading volume of 7,430,000 shares, the days-to-cover ratio is presently 3.7 days.
View Clover Health Investments' Short Interest
.

When is Clover Health Investments' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our CLOV earnings forecast
.

What guidance has Clover Health Investments issued on next quarter's earnings?

Clover Health Investments issued an update on its FY 2023 earnings guidance on Thursday, December, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion.

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.99%), Charles Schwab Investment Management Inc. (0.35%), Cubist Systematic Strategies LLC (0.24%), Northern Trust Corp (0.18%), Swiss National Bank (0.15%) and Goldman Sachs Group Inc. (0.11%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro.
View institutional ownership trends
.

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLOV) was last updated on 2/25/2024 by MarketBeat.com Staff